SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Passage BIO, Inc. (PASG) (CIK 0001787297) (PASG) — Jan 19, 2021

Passage BIO, Inc. (PASG) (CIK 0001787297)
Date: Jan. 19, 2021 · CIK: 0001787297 · Accession: 0001104659-21-005393

AI Filing Summary & Sentiment

File numbers found in text: 333-252213

Date
January 19, 2021
Author
passage bio
Form
CORRESP
Company
Passage BIO, Inc. (PASG) (CIK 0001787297)

Letter

Passage Bio, Inc.

2001 Market Street, 28th Floor

Philadelphia, PA 19103

January 19, 2021

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, DC 20549

Attention:

Tim Buchmiller

Re: Passage Bio, Inc. Registration Statement on Form S-1 (File No. 333-252213) originally filed January 19, 2021.

Requested Date: January 21, 2021

Requested Time: 4:30 PM Eastern Time

Ladies and Gentlemen:

Passage Bio, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission take appropriate action to declare the above-captioned Registration Statements on Form S-1 effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable.

The Registrant hereby authorizes Robert A. Freedman or Ryan Mitteness, both of whom are attorneys with the Registrant’s outside legal counsel, Fenwick & West LLP, to orally modify or withdraw this request for acceleration.

The Registrant requests that it be notified of such effectiveness by a telephone call to Mr. Freedman at (650) 335-7292 or, in his absence, Mr. Mitteness at (206)-389-4533.

* * *

Sincerely,
passage bio,
inc.

Show Raw Text
CORRESP
1
filename1.htm

Passage Bio, Inc.

2001 Market Street, 28th Floor

Philadelphia, PA 19103

January 19, 2021

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, DC 20549

        Attention:

        Tim Buchmiller

    Re:
    Passage Bio, Inc. Registration Statement on Form S-1 (File No. 333-252213) originally filed January 19, 2021.

Requested Date: January 21, 2021

Requested Time: 4:30 PM Eastern Time

Ladies and Gentlemen:

Passage Bio, Inc.
(the “Registrant”) hereby requests that the Securities and Exchange Commission take appropriate action
to declare the above-captioned Registration Statements on Form S-1 effective at the “Requested Date” and “Requested
Time” set forth above or as soon thereafter as practicable.

The Registrant hereby
authorizes Robert A. Freedman or Ryan Mitteness, both of whom are attorneys with the Registrant’s outside legal counsel,
Fenwick & West LLP, to orally modify or withdraw this request for acceleration.

The Registrant requests
that it be notified of such effectiveness by a telephone call to Mr. Freedman at (650) 335-7292 or, in his absence, Mr. Mitteness
at (206)-389-4533.

* * *

  Sincerely,

  passage bio,
               inc.

 By:  /s/
                                         Bruce Goldsmith

    Bruce Goldsmith, Ph.D.

    Chief
                                         Executive Officer

    cc:
    Richard S. Morris, Chief Financial Officer

    Passage
    Bio, Inc.

    Ryan
    Mitteness, Esq.

    Robert
    A. Freedman, Esq.

    Fenwick
    & West LLP